DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

Recruiting now

Conditions studied: Open Angle Glaucoma (OAG)

In brief

DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.

Key facts

Study ID

NCT06933836

Run by

Barnet Dulaney Perkins Eye Centers

People needed

55

Starts

2025-03-31

Expected to finish

2027-12-31

Last updated by the study team

2025-04-18

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Primary open angle glaucoma
• Patients age 30 or greater with an IOP of 18-26 mmHg
• Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines)
• DSLT procedure

You may not qualify if…

• History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery
• Angle closure patients
• Ocular Hypertension
• Baseline VF MD of worse than -12dB
• Uncontrolled systemic microvascular disease (eg. HTN, DM)
• Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium)

Where it is running

• Barnet Dulaney Perkins Eye Centers — Mesa, Arizona, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.